ARTICLE | Clinical News
HpNSCs: Phase I started
March 14, 2016 7:00 AM UTC
International Stem Cell began an open-label, dose-escalation, Australian Phase I trial to evaluate 3 dose levels of 30-70 million hpSC-derived neuronal cells injected intracerebrally into the striatum...